Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1418-1427

  Egan, Andrea F ^a   Blackman, Michael J ^b   Kaslow, David C ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MEROZOITE SURFACE PROTEIN 1; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; TETANUS TOXOID;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AOTUS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFECTION PREVENTION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REINFECTION; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; AOTUS TRIVIRGATUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; VACCINATION; VACCINES, SYNTHETIC;

EID: 0033982987     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1418-1427.2000     Document Type: Article

References (27)

1. Al-Yuman, F., B. Genton, R. F. Anders, M. Falk, T. Triglia, D. Lewis, J. Hii, H.-P. Beck, and M. Alpers. 1994. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-1 and malaria morbidity in a highly endemic area of Papua New Guinea. Am. J. Trop. Med. Hyg. 51: 593-602.
2. Blackman, M. J., H.-G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
3. 33 as a non-covalently associated complex with other fragments of the MSP-1. Mol. Biochem. Parasitol. 50:307-316.
4. Blackman, M. J., I. T. Ling, S. C. Nicholls, and A. A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-34.
5. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
6. Blackman, M. J., H. Whittle, and A. A. Holder. 1991. Processing of the Plasmodium falciparum merozoite surface protein-1: identification of a 33 kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 49:35-44.
7. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. N. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
8. Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. N. Hui. 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
9. Cooper, J. A., L. T. Cooper, and A. J. Saul. 1992. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol. Biochem. Parasitol. 51:301-312.
10. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467.
11. Deans, J. A., A. M. Knight, W. C. Jean, A. P. Waters, S. Cohen, and G. H. Mitchell. 1988. Vaccination trials in Rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66-kDa merozoite antigen. Parasite Immunol. 10:535-552.
12. Egan, A. F., J. A. Chappel, P. A. Burghaus, P. Druilhe, A. A. Holder, and E. M. Riley. 1999. Human antibodies to the C-terminal fragment of Plasmodium falciparum merozoite surface protein-1 directly inhibit merozoite invasion in vitro and mediate antibody-dependent cell-mediated inhibition of parasite growth. Parasite Immunol. 21:133-139.
13. Egan, A. F., J. S. Morris, G. Barnish, S. Allen, B. Greenwood, D. C. Kaslow, A. A. Holder, and E. M. Riley. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19 kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
14. Etlinger, H. M., P. Caspers, H. Matile, H.-J. Schenfield, D. Stueber, and B. Tacaks. 1991. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect. Immun. 59:3498-3503.
15. Guevara Patino, J. A., A. A. Holder, J. S. McBride, and M. J. Blackman. 1997. Antibodies that inhibit malaria merozoite protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 184:1689-1699.
16. Hall, R., J. E. Hyde, M. Goman, D. L. Simmons, I. A. Hope, M. Mackay, and J. Scaife. 1984. Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature 311:379-382.
17. Holder, A. A., M. J. Lockyer, K. G. Odink, J. S. Sandhu, V. Riveros-Moreno, S. C. Nicholls, Y. Hillman, L. S. Davey, M. L. V. Tizard, R. T. Schwarz, and R. R. Freeman. 1985. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature 317:270-273.
18. Kaslow, D. C., and J. Shiloach. 1994. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. Bio/Technology 12:494-499.
19. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
20. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
21. McBride, J. S., and H.-G. Heidrich. 1987. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:71-84,
22. Miller, L. H., T. Roberts, M. Shahabuddin, and T. F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1-14.
23. Pirson, P. J., and M. E. Perkins. 1985. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J. Immunol. 134:1946-1951.
24. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H.-J. Schonfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321-337.
25. Siddiqui W. A., L. Q. Tam, S. C. Kan, K. J. Kramer, S. E. Case, K. L. Palmer, K. M. Yamaga, and G. S. Hui. 1986. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. Infect. Immun. 52:314-318.
26. Siddiqui, W. A., L. W. Tam, K. J. Kramer, J. S. N. Hui, S. E. Case, K. M. Yamage, S. P. Chang, E. B. T. Chan, and S. Kan. 1987. Merozoite surface coat surface protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 84:3014-3018.
27. Snow, R. W., J. A. Omumbo, B. Lowe, C. S. Molyneux, J. O. Obiero, A. Palmer, M. W. Weber, M. Pinder, B. Nahlen, C. Obonyo, C. Newbold, S. Gupter, and K. Marsh. 1997. Relationship between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349:1650-1654.